Comparative Immunogenicity Study Comparing TPI-120 to Neulasta® in Healthy Adult Subjects
Clinical trial NCT03202927 · COMPLETED
Trial details
- NCT number
- NCT03202927
- Sponsor
- Adello Biologics, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-25
- Primary completion
- 2018-03-01
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.